ReIMAGINE study demonstrates feasibility of MRI-enhanced prostate cancer screening

Recently published in BMJ Oncology, results from the ReIMAGINE study demonstrate the feasibility of combining MRI with Prostate Specific Antigen (PSA) testing to improve the detection of prostate cancer (PC). Currently, men in the UK aged 50 or over can request a PSA test, if they have concerns that they have PC or exhibit PC symptoms. When compared to other countries, such as the USA, France or Italy, the UK exhibits a relatively high PC-specific mortality rate, suggesting improvements to the UK’s PC screening process are long overdue. The combination of a PSA test and rectal examination, followed by a...